CABG the clear choice for patients with diabetes and multivessel disease
- 1 March 2018
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 391 (10124) , 913-914
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- The coronary heart teamCurrent Opinion in Cardiology, 2017
- Meta-analysis of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery DiseaseThe American Journal of Cardiology, 2017
- Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main and Multivessel Coronary Artery DiseaseCirculation, 2017
- What is the optimum adjunctive reperfusion strategy for primary percutaneous coronary intervention?The Lancet, 2013
- Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trialThe Lancet, 2013
- Strategies for Multivessel Revascularization in Patients with DiabetesNew England Journal of Medicine, 2012
- EXAMINATION of new drug-eluting stents—top of the class!The Lancet, 2012
- Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosisThe Lancet, 2008
- Myocardial Infarction and Cardiac Mortality in the Bypass Angioplasty Revascularization Investigation (BARI) Randomized TrialCirculation, 1997
- A Randomized Trial Comparing Coronary Angioplasty with Coronary Bypass SurgeryNew England Journal of Medicine, 1994